Efficient induction of cytotoxic T lymphocytes specific for severe acute respiratory syndrome (SARS)-associated coronavirus by immunization with surface-linked liposomal peptides derived from a non-structural polyprotein 1a
Identifieur interne : 000176 ( PascalFrancis/Corpus ); précédent : 000175; suivant : 000177Efficient induction of cytotoxic T lymphocytes specific for severe acute respiratory syndrome (SARS)-associated coronavirus by immunization with surface-linked liposomal peptides derived from a non-structural polyprotein 1a
Auteurs : Shunsuke Kohyama ; Satoshi Ohno ; Tatsuya Suda ; Maiko Taneichi ; Shoichi Yokoyama ; Masahito Mori ; Akiharu Kobavashi ; Hidenori Havashi ; Tetsuva Uchida ; Masanori MatsuiSource :
- Antiviral research [ 0166-3542 ] ; 2009.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
Abstract
Spike and nucleocapsid are structural proteins of severe acute respiratory syndrome (SARS)-associated coronavirus (SARS-CoV) and major targets for cytotoxic T lymphocytes (CTLs). In contrast, non-structural proteins encoded by two-thirds of viral genome are poorly characterized for cell-mediated immunity. We previously demonstrated that nucleocapsid-derived peptides chemically coupled to the surface of liposomes effectively elicited SARS-CoV-specific CTLs in mice. Here, we attempted to identify HLA-A*0201-restricted CTL epitopes derived from a non-structural polyprotein 1a (ppla) of SARS-CoV, and investigated whether liposomal peptides derived from pp1a were effective for CTL induction. Out of 30 peptides predicted on computational algorithms, nine peptides could significantly induce interferon gamma (IFN-γ)-producing CD8+ T cells in mice. These peptides were coupled to the surface of liposomes, and inoculated into mice. Six liposomal peptides effectively induced IFN-γ-producing CD8+ T cells and seven liposomal peptides including the six peptides primed CTLs showing in vivo killing activities. Further, CTLs induced by the seven liposomal peptides lysed an HLA-A*0201 positive cell line expressing naturally processed, ppla-derived peptides. Of note, one of the liposomal peptides induced high numbers of long-lasting memory CTLs. These data suggest that surface-linked liposomal peptides derived from ppla might offer an efficient CTL-based vaccine against SARS.
Notice en format standard (ISO 2709)
Pour connaître la documentation sur le format Inist Standard.
pA |
|
---|
Format Inist (serveur)
NO : | PASCAL 09-0466845 INIST |
---|---|
ET : | Efficient induction of cytotoxic T lymphocytes specific for severe acute respiratory syndrome (SARS)-associated coronavirus by immunization with surface-linked liposomal peptides derived from a non-structural polyprotein 1a |
AU : | KOHYAMA (Shunsuke); OHNO (Satoshi); SUDA (Tatsuya); TANEICHI (Maiko); YOKOYAMA (Shoichi); MORI (Masahito); KOBAVASHI (Akiharu); HAVASHI (Hidenori); UCHIDA (Tetsuva); MATSUI (Masanori) |
AF : | Department of Microbiology, Faculty of Medicine, Saitama Medical University, Moroyama-cho/Iruma-gun, Saitama 350-0495/Japon (1 aut., 2 aut., 3 aut., 10 aut.); Department of Pathological Biochemistry, Faculty of Pharmaceutical Sciences, Josai University/Sakado-city, Saitama 350-0295/Japon (1 aut., 2 aut., 8 aut.); Department of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases/Musashimurayama-city, Tokyo 208-0011/Japon (4 aut., 9 aut.); Drug Delivery System Development Division, Nippon Oil and Fat Corporation/Tokyo 150-6019/Japon (5 aut., 6 aut., 7 aut.) |
DT : | Publication en série; Niveau analytique |
SO : | Antiviral research; ISSN 0166-3542; Coden ARSRDR; Pays-Bas; Da. 2009; Vol. 84; No. 2; Pp. 168-177; Bibl. 1 p. |
LA : | Anglais |
EA : | Spike and nucleocapsid are structural proteins of severe acute respiratory syndrome (SARS)-associated coronavirus (SARS-CoV) and major targets for cytotoxic T lymphocytes (CTLs). In contrast, non-structural proteins encoded by two-thirds of viral genome are poorly characterized for cell-mediated immunity. We previously demonstrated that nucleocapsid-derived peptides chemically coupled to the surface of liposomes effectively elicited SARS-CoV-specific CTLs in mice. Here, we attempted to identify HLA-A*0201-restricted CTL epitopes derived from a non-structural polyprotein 1a (ppla) of SARS-CoV, and investigated whether liposomal peptides derived from pp1a were effective for CTL induction. Out of 30 peptides predicted on computational algorithms, nine peptides could significantly induce interferon gamma (IFN-γ)-producing CD8+ T cells in mice. These peptides were coupled to the surface of liposomes, and inoculated into mice. Six liposomal peptides effectively induced IFN-γ-producing CD8+ T cells and seven liposomal peptides including the six peptides primed CTLs showing in vivo killing activities. Further, CTLs induced by the seven liposomal peptides lysed an HLA-A*0201 positive cell line expressing naturally processed, ppla-derived peptides. Of note, one of the liposomal peptides induced high numbers of long-lasting memory CTLs. These data suggest that surface-linked liposomal peptides derived from ppla might offer an efficient CTL-based vaccine against SARS. |
CC : | 002B02S05; 002B05C02C |
FD : | Induction; Lymphocyte T cytotoxique; Syndrome respiratoire aigu sévère; Virus syndrome respiratoire aigu sévère; Immunisation; Vaccin; Vaccination; Liposome; Polyprotéine; Prévention; Immunoprophylaxie; Immunité cellulaire; Composé conjugué; Protéine non structurale |
FG : | Virose; Infection; Coronavirus; Coronaviridae; Nidovirales; Virus; Pathologie de l'appareil respiratoire; Pathologie des poumons |
ED : | Induction; Cytotoxic T lymphocyte; Severe acute respiratory syndrome; Severe acute respiratory syndrome virus; Immunization; Vaccine; Vaccination; Liposome; Polyprotein; Prevention; Immunoprophylaxis; Cellular immunity; Conjugated compound |
EG : | Viral disease; Infection; Coronavirus; Coronaviridae; Nidovirales; Virus; Respiratory disease; Lung disease |
SD : | Inducción; Linfocito T citotóxico; Síndrome respiratorio agudo severo; Severe acute respiratory syndrome virus; Inmunización; Vacuna; Vacunación; Liposoma; Polyproteina; Prevención; Inmunoprofilaxia; Inmunidad celular; Compuesto conjugado |
LO : | INIST-18839.354000170327240070 |
ID : | 09-0466845 |
Links to Exploration step
Pascal:09-0466845Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Efficient induction of cytotoxic T lymphocytes specific for severe acute respiratory syndrome (SARS)-associated coronavirus by immunization with surface-linked liposomal peptides derived from a non-structural polyprotein 1a</title>
<author><name sortKey="Kohyama, Shunsuke" sort="Kohyama, Shunsuke" uniqKey="Kohyama S" first="Shunsuke" last="Kohyama">Shunsuke Kohyama</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Microbiology, Faculty of Medicine, Saitama Medical University, Moroyama-cho</s1>
<s2>Iruma-gun, Saitama 350-0495</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="02"><s1>Department of Pathological Biochemistry, Faculty of Pharmaceutical Sciences, Josai University</s1>
<s2>Sakado-city, Saitama 350-0295</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Ohno, Satoshi" sort="Ohno, Satoshi" uniqKey="Ohno S" first="Satoshi" last="Ohno">Satoshi Ohno</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Microbiology, Faculty of Medicine, Saitama Medical University, Moroyama-cho</s1>
<s2>Iruma-gun, Saitama 350-0495</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="02"><s1>Department of Pathological Biochemistry, Faculty of Pharmaceutical Sciences, Josai University</s1>
<s2>Sakado-city, Saitama 350-0295</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Suda, Tatsuya" sort="Suda, Tatsuya" uniqKey="Suda T" first="Tatsuya" last="Suda">Tatsuya Suda</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Microbiology, Faculty of Medicine, Saitama Medical University, Moroyama-cho</s1>
<s2>Iruma-gun, Saitama 350-0495</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Taneichi, Maiko" sort="Taneichi, Maiko" uniqKey="Taneichi M" first="Maiko" last="Taneichi">Maiko Taneichi</name>
<affiliation><inist:fA14 i1="03"><s1>Department of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases</s1>
<s2>Musashimurayama-city, Tokyo 208-0011</s2>
<s3>JPN</s3>
<sZ>4 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Yokoyama, Shoichi" sort="Yokoyama, Shoichi" uniqKey="Yokoyama S" first="Shoichi" last="Yokoyama">Shoichi Yokoyama</name>
<affiliation><inist:fA14 i1="04"><s1>Drug Delivery System Development Division, Nippon Oil and Fat Corporation</s1>
<s2>Tokyo 150-6019</s2>
<s3>JPN</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Mori, Masahito" sort="Mori, Masahito" uniqKey="Mori M" first="Masahito" last="Mori">Masahito Mori</name>
<affiliation><inist:fA14 i1="04"><s1>Drug Delivery System Development Division, Nippon Oil and Fat Corporation</s1>
<s2>Tokyo 150-6019</s2>
<s3>JPN</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Kobavashi, Akiharu" sort="Kobavashi, Akiharu" uniqKey="Kobavashi A" first="Akiharu" last="Kobavashi">Akiharu Kobavashi</name>
<affiliation><inist:fA14 i1="04"><s1>Drug Delivery System Development Division, Nippon Oil and Fat Corporation</s1>
<s2>Tokyo 150-6019</s2>
<s3>JPN</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Havashi, Hidenori" sort="Havashi, Hidenori" uniqKey="Havashi H" first="Hidenori" last="Havashi">Hidenori Havashi</name>
<affiliation><inist:fA14 i1="02"><s1>Department of Pathological Biochemistry, Faculty of Pharmaceutical Sciences, Josai University</s1>
<s2>Sakado-city, Saitama 350-0295</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Uchida, Tetsuva" sort="Uchida, Tetsuva" uniqKey="Uchida T" first="Tetsuva" last="Uchida">Tetsuva Uchida</name>
<affiliation><inist:fA14 i1="03"><s1>Department of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases</s1>
<s2>Musashimurayama-city, Tokyo 208-0011</s2>
<s3>JPN</s3>
<sZ>4 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Matsui, Masanori" sort="Matsui, Masanori" uniqKey="Matsui M" first="Masanori" last="Matsui">Masanori Matsui</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Microbiology, Faculty of Medicine, Saitama Medical University, Moroyama-cho</s1>
<s2>Iruma-gun, Saitama 350-0495</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">09-0466845</idno>
<date when="2009">2009</date>
<idno type="stanalyst">PASCAL 09-0466845 INIST</idno>
<idno type="RBID">Pascal:09-0466845</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000176</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Efficient induction of cytotoxic T lymphocytes specific for severe acute respiratory syndrome (SARS)-associated coronavirus by immunization with surface-linked liposomal peptides derived from a non-structural polyprotein 1a</title>
<author><name sortKey="Kohyama, Shunsuke" sort="Kohyama, Shunsuke" uniqKey="Kohyama S" first="Shunsuke" last="Kohyama">Shunsuke Kohyama</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Microbiology, Faculty of Medicine, Saitama Medical University, Moroyama-cho</s1>
<s2>Iruma-gun, Saitama 350-0495</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="02"><s1>Department of Pathological Biochemistry, Faculty of Pharmaceutical Sciences, Josai University</s1>
<s2>Sakado-city, Saitama 350-0295</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Ohno, Satoshi" sort="Ohno, Satoshi" uniqKey="Ohno S" first="Satoshi" last="Ohno">Satoshi Ohno</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Microbiology, Faculty of Medicine, Saitama Medical University, Moroyama-cho</s1>
<s2>Iruma-gun, Saitama 350-0495</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="02"><s1>Department of Pathological Biochemistry, Faculty of Pharmaceutical Sciences, Josai University</s1>
<s2>Sakado-city, Saitama 350-0295</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Suda, Tatsuya" sort="Suda, Tatsuya" uniqKey="Suda T" first="Tatsuya" last="Suda">Tatsuya Suda</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Microbiology, Faculty of Medicine, Saitama Medical University, Moroyama-cho</s1>
<s2>Iruma-gun, Saitama 350-0495</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Taneichi, Maiko" sort="Taneichi, Maiko" uniqKey="Taneichi M" first="Maiko" last="Taneichi">Maiko Taneichi</name>
<affiliation><inist:fA14 i1="03"><s1>Department of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases</s1>
<s2>Musashimurayama-city, Tokyo 208-0011</s2>
<s3>JPN</s3>
<sZ>4 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Yokoyama, Shoichi" sort="Yokoyama, Shoichi" uniqKey="Yokoyama S" first="Shoichi" last="Yokoyama">Shoichi Yokoyama</name>
<affiliation><inist:fA14 i1="04"><s1>Drug Delivery System Development Division, Nippon Oil and Fat Corporation</s1>
<s2>Tokyo 150-6019</s2>
<s3>JPN</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Mori, Masahito" sort="Mori, Masahito" uniqKey="Mori M" first="Masahito" last="Mori">Masahito Mori</name>
<affiliation><inist:fA14 i1="04"><s1>Drug Delivery System Development Division, Nippon Oil and Fat Corporation</s1>
<s2>Tokyo 150-6019</s2>
<s3>JPN</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Kobavashi, Akiharu" sort="Kobavashi, Akiharu" uniqKey="Kobavashi A" first="Akiharu" last="Kobavashi">Akiharu Kobavashi</name>
<affiliation><inist:fA14 i1="04"><s1>Drug Delivery System Development Division, Nippon Oil and Fat Corporation</s1>
<s2>Tokyo 150-6019</s2>
<s3>JPN</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Havashi, Hidenori" sort="Havashi, Hidenori" uniqKey="Havashi H" first="Hidenori" last="Havashi">Hidenori Havashi</name>
<affiliation><inist:fA14 i1="02"><s1>Department of Pathological Biochemistry, Faculty of Pharmaceutical Sciences, Josai University</s1>
<s2>Sakado-city, Saitama 350-0295</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Uchida, Tetsuva" sort="Uchida, Tetsuva" uniqKey="Uchida T" first="Tetsuva" last="Uchida">Tetsuva Uchida</name>
<affiliation><inist:fA14 i1="03"><s1>Department of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases</s1>
<s2>Musashimurayama-city, Tokyo 208-0011</s2>
<s3>JPN</s3>
<sZ>4 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Matsui, Masanori" sort="Matsui, Masanori" uniqKey="Matsui M" first="Masanori" last="Matsui">Masanori Matsui</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Microbiology, Faculty of Medicine, Saitama Medical University, Moroyama-cho</s1>
<s2>Iruma-gun, Saitama 350-0495</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Antiviral research</title>
<title level="j" type="abbreviated">Antivir. res.</title>
<idno type="ISSN">0166-3542</idno>
<imprint><date when="2009">2009</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Antiviral research</title>
<title level="j" type="abbreviated">Antivir. res.</title>
<idno type="ISSN">0166-3542</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Cellular immunity</term>
<term>Conjugated compound</term>
<term>Cytotoxic T lymphocyte</term>
<term>Immunization</term>
<term>Immunoprophylaxis</term>
<term>Induction</term>
<term>Liposome</term>
<term>Polyprotein</term>
<term>Prevention</term>
<term>Severe acute respiratory syndrome</term>
<term>Severe acute respiratory syndrome virus</term>
<term>Vaccination</term>
<term>Vaccine</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Induction</term>
<term>Lymphocyte T cytotoxique</term>
<term>Syndrome respiratoire aigu sévère</term>
<term>Virus syndrome respiratoire aigu sévère</term>
<term>Immunisation</term>
<term>Vaccin</term>
<term>Vaccination</term>
<term>Liposome</term>
<term>Polyprotéine</term>
<term>Prévention</term>
<term>Immunoprophylaxie</term>
<term>Immunité cellulaire</term>
<term>Composé conjugué</term>
<term>Protéine non structurale</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Spike and nucleocapsid are structural proteins of severe acute respiratory syndrome (SARS)-associated coronavirus (SARS-CoV) and major targets for cytotoxic T lymphocytes (CTLs). In contrast, non-structural proteins encoded by two-thirds of viral genome are poorly characterized for cell-mediated immunity. We previously demonstrated that nucleocapsid-derived peptides chemically coupled to the surface of liposomes effectively elicited SARS-CoV-specific CTLs in mice. Here, we attempted to identify HLA-A<sup>*</sup>
0201-restricted CTL epitopes derived from a non-structural polyprotein 1a (ppla) of SARS-CoV, and investigated whether liposomal peptides derived from pp1a were effective for CTL induction. Out of 30 peptides predicted on computational algorithms, nine peptides could significantly induce interferon gamma (IFN-γ)-producing CD8<sup>+</sup>
T cells in mice. These peptides were coupled to the surface of liposomes, and inoculated into mice. Six liposomal peptides effectively induced IFN-γ-producing CD8<sup>+</sup>
T cells and seven liposomal peptides including the six peptides primed CTLs showing in vivo killing activities. Further, CTLs induced by the seven liposomal peptides lysed an HLA-A<sup>*</sup>
0201 positive cell line expressing naturally processed, ppla-derived peptides. Of note, one of the liposomal peptides induced high numbers of long-lasting memory CTLs. These data suggest that surface-linked liposomal peptides derived from ppla might offer an efficient CTL-based vaccine against SARS.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0166-3542</s0>
</fA01>
<fA02 i1="01"><s0>ARSRDR</s0>
</fA02>
<fA03 i2="1"><s0>Antivir. res.</s0>
</fA03>
<fA05><s2>84</s2>
</fA05>
<fA06><s2>2</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Efficient induction of cytotoxic T lymphocytes specific for severe acute respiratory syndrome (SARS)-associated coronavirus by immunization with surface-linked liposomal peptides derived from a non-structural polyprotein 1a</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>KOHYAMA (Shunsuke)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>OHNO (Satoshi)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>SUDA (Tatsuya)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>TANEICHI (Maiko)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>YOKOYAMA (Shoichi)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>MORI (Masahito)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>KOBAVASHI (Akiharu)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>HAVASHI (Hidenori)</s1>
</fA11>
<fA11 i1="09" i2="1"><s1>UCHIDA (Tetsuva)</s1>
</fA11>
<fA11 i1="10" i2="1"><s1>MATSUI (Masanori)</s1>
</fA11>
<fA14 i1="01"><s1>Department of Microbiology, Faculty of Medicine, Saitama Medical University, Moroyama-cho</s1>
<s2>Iruma-gun, Saitama 350-0495</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>10 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Department of Pathological Biochemistry, Faculty of Pharmaceutical Sciences, Josai University</s1>
<s2>Sakado-city, Saitama 350-0295</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>8 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Department of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases</s1>
<s2>Musashimurayama-city, Tokyo 208-0011</s2>
<s3>JPN</s3>
<sZ>4 aut.</sZ>
<sZ>9 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>Drug Delivery System Development Division, Nippon Oil and Fat Corporation</s1>
<s2>Tokyo 150-6019</s2>
<s3>JPN</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</fA14>
<fA20><s1>168-177</s1>
</fA20>
<fA21><s1>2009</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>18839</s2>
<s5>354000170327240070</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2009 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>1 p.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>09-0466845</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Antiviral research</s0>
</fA64>
<fA66 i1="01"><s0>NLD</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Spike and nucleocapsid are structural proteins of severe acute respiratory syndrome (SARS)-associated coronavirus (SARS-CoV) and major targets for cytotoxic T lymphocytes (CTLs). In contrast, non-structural proteins encoded by two-thirds of viral genome are poorly characterized for cell-mediated immunity. We previously demonstrated that nucleocapsid-derived peptides chemically coupled to the surface of liposomes effectively elicited SARS-CoV-specific CTLs in mice. Here, we attempted to identify HLA-A<sup>*</sup>
0201-restricted CTL epitopes derived from a non-structural polyprotein 1a (ppla) of SARS-CoV, and investigated whether liposomal peptides derived from pp1a were effective for CTL induction. Out of 30 peptides predicted on computational algorithms, nine peptides could significantly induce interferon gamma (IFN-γ)-producing CD8<sup>+</sup>
T cells in mice. These peptides were coupled to the surface of liposomes, and inoculated into mice. Six liposomal peptides effectively induced IFN-γ-producing CD8<sup>+</sup>
T cells and seven liposomal peptides including the six peptides primed CTLs showing in vivo killing activities. Further, CTLs induced by the seven liposomal peptides lysed an HLA-A<sup>*</sup>
0201 positive cell line expressing naturally processed, ppla-derived peptides. Of note, one of the liposomal peptides induced high numbers of long-lasting memory CTLs. These data suggest that surface-linked liposomal peptides derived from ppla might offer an efficient CTL-based vaccine against SARS.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B02S05</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B05C02C</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Induction</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Induction</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Inducción</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Lymphocyte T cytotoxique</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Cytotoxic T lymphocyte</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Linfocito T citotóxico</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Syndrome respiratoire aigu sévère</s0>
<s2>NM</s2>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Severe acute respiratory syndrome</s0>
<s2>NM</s2>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Síndrome respiratorio agudo severo</s0>
<s2>NM</s2>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Virus syndrome respiratoire aigu sévère</s0>
<s2>NW</s2>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Severe acute respiratory syndrome virus</s0>
<s2>NW</s2>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Severe acute respiratory syndrome virus</s0>
<s2>NW</s2>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Immunisation</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Immunization</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Inmunización</s0>
<s5>05</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Vaccin</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Vaccine</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Vacuna</s0>
<s5>06</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Vaccination</s0>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Vaccination</s0>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Vacunación</s0>
<s5>07</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Liposome</s0>
<s5>09</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Liposome</s0>
<s5>09</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Liposoma</s0>
<s5>09</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Polyprotéine</s0>
<s5>11</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Polyprotein</s0>
<s5>11</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Polyproteina</s0>
<s5>11</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Prévention</s0>
<s5>12</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Prevention</s0>
<s5>12</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Prevención</s0>
<s5>12</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE"><s0>Immunoprophylaxie</s0>
<s5>13</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG"><s0>Immunoprophylaxis</s0>
<s5>13</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA"><s0>Inmunoprofilaxia</s0>
<s5>13</s5>
</fC03>
<fC03 i1="12" i2="X" l="FRE"><s0>Immunité cellulaire</s0>
<s5>14</s5>
</fC03>
<fC03 i1="12" i2="X" l="ENG"><s0>Cellular immunity</s0>
<s5>14</s5>
</fC03>
<fC03 i1="12" i2="X" l="SPA"><s0>Inmunidad celular</s0>
<s5>14</s5>
</fC03>
<fC03 i1="13" i2="X" l="FRE"><s0>Composé conjugué</s0>
<s5>15</s5>
</fC03>
<fC03 i1="13" i2="X" l="ENG"><s0>Conjugated compound</s0>
<s5>15</s5>
</fC03>
<fC03 i1="13" i2="X" l="SPA"><s0>Compuesto conjugado</s0>
<s5>15</s5>
</fC03>
<fC03 i1="14" i2="X" l="FRE"><s0>Protéine non structurale</s0>
<s4>INC</s4>
<s5>86</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Virose</s0>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Viral disease</s0>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Virosis</s0>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Infection</s0>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Infection</s0>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Infección</s0>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Coronavirus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Coronavirus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Coronavirus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Coronaviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Coronaviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Coronaviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Nidovirales</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Nidovirales</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Nidovirales</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="07" i2="X" l="FRE"><s0>Pathologie de l'appareil respiratoire</s0>
<s5>37</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG"><s0>Respiratory disease</s0>
<s5>37</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA"><s0>Aparato respiratorio patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="08" i2="X" l="FRE"><s0>Pathologie des poumons</s0>
<s5>38</s5>
</fC07>
<fC07 i1="08" i2="X" l="ENG"><s0>Lung disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="08" i2="X" l="SPA"><s0>Pulmón patología</s0>
<s5>38</s5>
</fC07>
<fN21><s1>341</s1>
</fN21>
</pA>
</standard>
<server><NO>PASCAL 09-0466845 INIST</NO>
<ET>Efficient induction of cytotoxic T lymphocytes specific for severe acute respiratory syndrome (SARS)-associated coronavirus by immunization with surface-linked liposomal peptides derived from a non-structural polyprotein 1a</ET>
<AU>KOHYAMA (Shunsuke); OHNO (Satoshi); SUDA (Tatsuya); TANEICHI (Maiko); YOKOYAMA (Shoichi); MORI (Masahito); KOBAVASHI (Akiharu); HAVASHI (Hidenori); UCHIDA (Tetsuva); MATSUI (Masanori)</AU>
<AF>Department of Microbiology, Faculty of Medicine, Saitama Medical University, Moroyama-cho/Iruma-gun, Saitama 350-0495/Japon (1 aut., 2 aut., 3 aut., 10 aut.); Department of Pathological Biochemistry, Faculty of Pharmaceutical Sciences, Josai University/Sakado-city, Saitama 350-0295/Japon (1 aut., 2 aut., 8 aut.); Department of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases/Musashimurayama-city, Tokyo 208-0011/Japon (4 aut., 9 aut.); Drug Delivery System Development Division, Nippon Oil and Fat Corporation/Tokyo 150-6019/Japon (5 aut., 6 aut., 7 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Antiviral research; ISSN 0166-3542; Coden ARSRDR; Pays-Bas; Da. 2009; Vol. 84; No. 2; Pp. 168-177; Bibl. 1 p.</SO>
<LA>Anglais</LA>
<EA>Spike and nucleocapsid are structural proteins of severe acute respiratory syndrome (SARS)-associated coronavirus (SARS-CoV) and major targets for cytotoxic T lymphocytes (CTLs). In contrast, non-structural proteins encoded by two-thirds of viral genome are poorly characterized for cell-mediated immunity. We previously demonstrated that nucleocapsid-derived peptides chemically coupled to the surface of liposomes effectively elicited SARS-CoV-specific CTLs in mice. Here, we attempted to identify HLA-A<sup>*</sup>
0201-restricted CTL epitopes derived from a non-structural polyprotein 1a (ppla) of SARS-CoV, and investigated whether liposomal peptides derived from pp1a were effective for CTL induction. Out of 30 peptides predicted on computational algorithms, nine peptides could significantly induce interferon gamma (IFN-γ)-producing CD8<sup>+</sup>
T cells in mice. These peptides were coupled to the surface of liposomes, and inoculated into mice. Six liposomal peptides effectively induced IFN-γ-producing CD8<sup>+</sup>
T cells and seven liposomal peptides including the six peptides primed CTLs showing in vivo killing activities. Further, CTLs induced by the seven liposomal peptides lysed an HLA-A<sup>*</sup>
0201 positive cell line expressing naturally processed, ppla-derived peptides. Of note, one of the liposomal peptides induced high numbers of long-lasting memory CTLs. These data suggest that surface-linked liposomal peptides derived from ppla might offer an efficient CTL-based vaccine against SARS.</EA>
<CC>002B02S05; 002B05C02C</CC>
<FD>Induction; Lymphocyte T cytotoxique; Syndrome respiratoire aigu sévère; Virus syndrome respiratoire aigu sévère; Immunisation; Vaccin; Vaccination; Liposome; Polyprotéine; Prévention; Immunoprophylaxie; Immunité cellulaire; Composé conjugué; Protéine non structurale</FD>
<FG>Virose; Infection; Coronavirus; Coronaviridae; Nidovirales; Virus; Pathologie de l'appareil respiratoire; Pathologie des poumons</FG>
<ED>Induction; Cytotoxic T lymphocyte; Severe acute respiratory syndrome; Severe acute respiratory syndrome virus; Immunization; Vaccine; Vaccination; Liposome; Polyprotein; Prevention; Immunoprophylaxis; Cellular immunity; Conjugated compound</ED>
<EG>Viral disease; Infection; Coronavirus; Coronaviridae; Nidovirales; Virus; Respiratory disease; Lung disease</EG>
<SD>Inducción; Linfocito T citotóxico; Síndrome respiratorio agudo severo; Severe acute respiratory syndrome virus; Inmunización; Vacuna; Vacunación; Liposoma; Polyproteina; Prevención; Inmunoprofilaxia; Inmunidad celular; Compuesto conjugado</SD>
<LO>INIST-18839.354000170327240070</LO>
<ID>09-0466845</ID>
</server>
</inist>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000176 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000176 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= PascalFrancis |étape= Corpus |type= RBID |clé= Pascal:09-0466845 |texte= Efficient induction of cytotoxic T lymphocytes specific for severe acute respiratory syndrome (SARS)-associated coronavirus by immunization with surface-linked liposomal peptides derived from a non-structural polyprotein 1a }}
![]() | This area was generated with Dilib version V0.6.33. | ![]() |